Myrtelle Announces Presentation of Encouraging Interim Results from its Phase 1/2 Gene Therapy Trial for Canavan Disease at the 2025 Cell & Gene Meeting on the Mesa
HiRO to Attend the 2026 ARCS Annual Conference in Sydney HiRO is excited to announce…
HiRO to Attend the 2026 ARCS Annual Conference in Sydney HiRO is excited to announce…
HiRO is heading to Melbourne this July for the ANZ Site Solutions Summit. The event…
HiRO is heading to Melbourne this July for the ANZ Site Solutions Summit. The event…